Skip to main content
VCbacked
Log inGet Started

Yellowstone Biosciences

Oxford, United Kingdom

Yellowstone seeks to identify a novel class of frequently expressed antigens that can be therapeutically targeted.

$20.9M raised
Jun 2024
Series A

Top Investors

Syncona Partners LLP

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Yellowstone Biosciences

How much funding has Yellowstone Biosciences raised?
Yellowstone Biosciences has raised $20.9M in total funding. The most recent round was Series A. The last funding was announced in June 2024.
Who are Yellowstone Biosciences's investors?
Yellowstone Biosciences's investors include Syncona Partners LLP.
Where is Yellowstone Biosciences headquartered?
Yellowstone Biosciences is headquartered in Oxford, United Kingdom.
What does Yellowstone Biosciences do?
Yellowstone seeks to identify a novel class of frequently expressed antigens that can be therapeutically targeted.
What stage is Yellowstone Biosciences at?
Yellowstone Biosciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Yellowstone Biosciences — Funding & Investors." VCBacked, June 20, 2024, https://www.vcbacked.co/company/yellowstone-biosciences. Accessed July 2, 2026.
APA
VCBacked. (2024). Yellowstone Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/yellowstone-biosciences
Wikipedia (cite web)
{{cite web |title=Yellowstone Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/yellowstone-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .